ENST00000740833.1:n.406+15204G>C

Variant summary

Our verdict is . The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000740833.1(ENSG00000296620):​n.406+15204G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.226 in 151,964 control chromosomes in the GnomAD database, including 4,213 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4213 hom., cov: 31)

Consequence

ENSG00000296620
ENST00000740833.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.213

Publications

6 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000740833.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.275 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000740833.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000296620
ENST00000740833.1
n.406+15204G>C
intron
N/A
ENSG00000296620
ENST00000740834.1
n.515+15204G>C
intron
N/A
ENSG00000296620
ENST00000740835.1
n.202+15482G>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34297
AN:
151846
Hom.:
4209
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.137
Gnomad AMI
AF:
0.315
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.297
Gnomad EAS
AF:
0.0168
Gnomad SAS
AF:
0.241
Gnomad FIN
AF:
0.233
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.278
Gnomad OTH
AF:
0.254
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.226
AC:
34322
AN:
151964
Hom.:
4213
Cov.:
31
AF XY:
0.226
AC XY:
16755
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.137
AC:
5684
AN:
41418
American (AMR)
AF:
0.268
AC:
4088
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.297
AC:
1029
AN:
3466
East Asian (EAS)
AF:
0.0168
AC:
87
AN:
5174
South Asian (SAS)
AF:
0.243
AC:
1171
AN:
4812
European-Finnish (FIN)
AF:
0.233
AC:
2455
AN:
10552
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.278
AC:
18893
AN:
67970
Other (OTH)
AF:
0.251
AC:
528
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1251
2502
3752
5003
6254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0865
Hom.:
147
Bravo
AF:
0.222
Asia WGS
AF:
0.124
AC:
430
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
11
DANN
Benign
0.76
PhyloP100
-0.21

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.